SWIFTBIO CONSULTING LTD
Executive Summary
SWIFTBIO CONSULTING LTD is currently experiencing liquidity challenges and a significant decline in equity, indicative of financial stress despite asset growth. Immediate steps to strengthen working capital, manage costs, and formalise director funding are crucial to restore financial health and ensure sustainable operations.
View Full Analysis Report →Financials
- Year ending
- 2024-09-30
- Total net assets
- £379£-13.24k vs previous year
- Total liabilities
- £-132.50k£-68.07k vs previous year
- Total assets
- £132.24k£54.19k vs previous year
Annual accounts
Financial Year Ending | |
---|---|
11 June 2025 | |
30 September 2024 | |
25 June 2024 | |
30 September 2023 | |
28 April 2023 | |
30 September 2022 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company